SMTI
Sanara Medtech IncNASDAQ
Healthcare • Medical Instruments & Supplies
Factor tilt: Micro-Cap Blend
$31.55-0.19%
Close Nov 6, 2026
- Market cap
- $289.12M
- 1 month
- -10.0%
- 3 months
- -7.9%
- 1 year
- +14.3%
- 52-week range
- $16.34$35.28
- Dividend
- No payments on record
- Short interest
- 10.0% of float374.8K shares · settled Oct 15, 2026 · +5.7% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $109.81M
- Net income
- -$32.01M
- Free cash flow
- $4.5M
- Book value
- $7.94M
- Total debt
- $48.53M
- P/E
- —
- Price / sales
- 2.6×
- Price / book
- 36.4×
- FCF yield
- +1.6%
- Net margin
- -29.2%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Sanara Medtech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Read more
It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
- Website
- sanaramedtech.com
- Headquarters
- Fort Worth, TX, United States
- Employees
- 108
- Listed
- Feb 22, 2011
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 26, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 11, 2026 | $28.1M | +8.9% | 93.0% | $1.8M | -$452.9K |
| Mar 2026filed May 12, 2026 | $27.8M | +18.6% | 91.0% | $2.6M | $459.0K |
| Dec 2025filed Mar 24, 2026 | $27.5M | +4.7% | 90.8% | $2.9M | -$1.6M |
| Sep 2025filed Nov 12, 2025 | $26.3M | +21.5% | 90.6% | $3.0M | -$30.4M |
| Jun 2025filed Aug 13, 2025 | $25.8M | +28.1% | 92.5% | -$31.3K | -$2.0M |
| Mar 2025filed May 14, 2025 | $23.4M | +26.4% | 89.2% | $825.5K | -$3.5M |
| Dec 2024filed Mar 25, 2025 | $26.3M | +48.7% | 91.4% | -$374.9K | -$1.5M |
| Sep 2024filed Nov 12, 2024 | $21.7M | +35.2% | 90.8% | -$1.9M | -$2.9M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 24, 2026 | $103.1M | +19.0% | 90.1% | $9.1M | -$37.6M |
| Dec 2024filed Mar 25, 2025 | $86.7M | +33.4% | 90.6% | -$6.7M | -$9.7M |
| Dec 2023filed Mar 25, 2024 | $65.0M | +41.8% | 87.9% | -$4.2M | -$4.3M |
| Dec 2022filed Mar 20, 2023 | $45.8M | +89.9% | 86.1% | -$12.5M | -$7.9M |
| Dec 2021filed Mar 31, 2022 | $24.1M | +54.9% | 90.4% | -$7.4M | -$7.9M |
| Dec 2020filed Mar 30, 2021 | $15.6M | +32.5% | 89.6% | -$5.0M | -$4.4M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched SMTI. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
374,810 shares short
+20,268 shares (+5.7%) vs Sep 30, 2026
10% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
354,542 shares short
+44,515 shares (+14.4%) vs Sep 15, 2026
9.4% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
310,027 shares short
+29,609 shares (+10.6%) vs Aug 31, 2026
6.5% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
280,418 shares short
+69,290 shares (+32.8%) vs Aug 14, 2026
5.9% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
211,128 shares short
-4,962 shares (-2.3%) vs Jul 31, 2026
4.5% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
216,090 shares short
-161,449 shares (-42.8%) vs Jul 15, 2026
4.6% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind SMTI’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 100 · reverse split
Effective May 10, 2019
Each 100 pre-split shares become 1 post-split share.
Source: EODHD
1 for 100 · reverse split
Effective Jun 26, 2002
Each 100 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if SMTI is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
6 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Insider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 3
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
74 filers reported a long position in SMTI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
65.2%
of the 1.8M shares 13-F filers reported
Moves vs Q1 2026
7 added3 trimmed
Net shares held
+16.8%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $5.9M · 248.8K shares | 248.8K | +8.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $4.6M · 194.9K shares | 194.9K | +28.8% |
| 3 | ROYAL BANK OF CANADA | $3.1M · 131K shares | 131K | -0.3% |
| 4 | Stonebridge Wealth Management, LLC | $3.1M · 129.5K shares | 129.5K | -5.4% |
| 5 | AQR CAPITAL MANAGEMENT LLC | $2.6M · 112.2K shares | 112.2K | +181% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $2.1M · 89.2K shares | 89.2K | +4.1% |
| 7 | GOLDMAN SACHS GROUP INC | $1.8M · 74.2K shares | 74.2K | +243.7% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | $1.6M · 67.4K shares | 67.4K | +4.2% |
| 9 | STATE STREET CORP | $1.5M · 63.5K shares | 63.5K | +1.2% |
| 10 | Squarepoint Ops LLC | $1.3M · 53.8K shares | 53.8K | -26.9% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of SMTI file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Jul 31, 2026 | TALL PINES CAPITAL LLC13G · passive · amended | 0%under 5% |
| Apr 14, 2026 | BAIRD TRUST Co13G · passive · amended | 0%under 5% |
Get the Full Analysis for SMTI
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.